70359-46-5 Brimonidine tartrate AKSci J98894
 
 
Loading Please Wait...
  J98894    
Brimonidine tartrate, 95%
 



IDENTITY
CAS Number:70359-46-5
MDL Number:MFCD07773072
MF:C11H10BrN5.C4H6O6
MW:442.22
SPECIFICATIONS & PROPERTIES
Purity:95%
Physical Form:Light yellow powder
Melting Point:213-218°C
Long-Term Storage:Store long-term at -20°C
UN #:UN2811
Hazard Class:6.1; Poison
Packing Group:III

BIOLOGICAL INFO
Solubility:Soluble in DMSO and Methanol

REVIEW
 Brimonidine is an alpha adrenergic receptor agonist (primarily alpha-2). It has a peak ocular hypotensive effect occurring at two hours post-dosing. Fluorophotometric studies in animals and humans suggest that Brimonidine has a dual mechanism of action by reducing aqueous humor production and increasing uveoscleral outflow.

REFERENCES
[1]Toris, C.; Camras, C.; Yablonski, M. (1999). Acute versus chronic effects of brimonidine on aqueous humor dynamics in ocular hypertensive patients. American journal of ophthalmology 128 (1): 8-14. PMID 10482088.

GHS

Pictograms

Signal Word
Warning

Hazard Statements
H315; H319; H335

Precautionary Statements
P261; P264; P271; P280; P302+P352; P304+P340; P305+P351+P338; P312; P321; P332+P313; P337+P313; P362; P403+P233; P405; P501

Current as of July 11, 2020


Download SDS

For research use only. Not for diagnostic or therapeutic use. Not for human use. AK Scientific, Inc. does not sell to individuals. If you are a first-time customer, please email for review at least two official business documents issued by your local jurisdiction, state/province, or country.


CATEGORIES
 APIs and Bioactives > Adrenergic Agonists


PubChem